Stanislava N. Vrublevskaya
Stanislava N. Vrublevskaya has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Dmitrii V. Gladyshev
Kurortny District City Hospital № 40
2 shared publications - A. A. Bachaev
Pavlov University
1 shared publication - Alexander A. Smirnov
Pavlov First Saint Petersburg State Medical University
1 shared publication - Andrey M. Sarana
Saint-Petersburg State University
1 shared publication Evgeny V. Vasiliev
The Saint Petersburg State Health Care Establishment the City Hospital №40
1 shared publicationG. V. Semikova
Pavlov University
1 shared publication
Latest Publications
- Open Access
- 22 October 2025
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Grekov's Bulletin of Surgery
- Vol. 184 (4) , 56-62
The first experience of application endoscopic sleeve gastroplasty in Russia: case series report
INTRODUCTION . Obesity is one of the most important problems of modern society, which requires the development of effective treatment methods. Endoscopic sleeve gastroplasty (ESG) is a minimally invasive approach to the treatment of obesity, which makes it possible to achieve significant weight loss and improve metabolic parameters. However, to date, there have been no studies on this technique in Russia. The OBJECTIVE was to evaluate the efficacy, safety, and aspects of the application of ESG using the example of two clinical cases. METHODS AND MATHERIALS. We present four cases of patients with stage II and III of obesity who underwent ESG. The patients met the inclusion criteria determined based on the Brazilian Consensus on Indications and Contraindications for this procedure. RESULTS . All patients demonstrated positive results after the procedure, including significant weight loss and improved quality of life without severe adverse events. CONCLUSION . This study is the first in Russia to highlight the importance of ESG as a promising method of obesity treatment. Further research is needed to assess the long-term outcomes and safety of this procedure.
- 22 October 2025
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Grekov's Bulletin of Surgery
- Vol. 184 (4) , 56-62
Open AccessThe first experience of application endoscopic sleeve gastroplasty in Russia: case series report
INTRODUCTION . Obesity is one of the most important problems of modern society, which requires the development of effective treatment methods. Endoscopic sleeve gastroplasty (ESG) is a minimally invasive approach to the treatment of obesity, which makes it possible to achieve significant weight loss and improve metabolic parameters. However, to date, there have been no studies on this technique in Russia. The OBJECTIVE was to evaluate the efficacy, safety, and aspects of the application of ESG using the example of two clinical cases. METHODS AND MATHERIALS. We present four cases of patients with stage II and III of obesity who underwent ESG. The patients met the inclusion criteria determined based on the Brazilian Consensus on Indications and Contraindications for this procedure. RESULTS . All patients demonstrated positive results after the procedure, including significant weight loss and improved quality of life without severe adverse events. CONCLUSION . This study is the first in Russia to highlight the importance of ESG as a promising method of obesity treatment. Further research is needed to assess the long-term outcomes and safety of this procedure.
- Open Access
- 21 December 2019
- Published by Endocrinology Research Centre in Obesity and metabolism
- Vol. 16 (3) , 3-10
Multiple effects of bariatric surgery on human biochemical status
Beneficial effect of bariatric surgery is expressed not only in reducing body weight, but also in improving the functioning of the body as a whole. On the one hand, numerous studies devoted to the investigations of specific mechanisms of the influence of bariatric surgery on the general condition of an organism testify to the enormous interest of scientists in this problem. On the other hand, the range of changes is so vast that it covers almost all physiological and biochemical processes. The most noticeable response to bariatric surgery is from the digestive (including the composition of the microbiota), immune (reducing the level of systemic and local inflammation), cardiovascular (reducing the risks of atherosclerosis and other diseases) systems. Partial or complete compensation of type 2 diabetes mellitus and metabolic syndrome also occurs. Among the variety of data, there is insufficient research on only standard biomarkers: leptin, C-reactive protein, interleukin 6, etc. A detailed study of the profiles of both circulating biomarkers and local ones is necessary. At the same time, it is obligate to continue to accumulate evidence on the positive effect of bariatric surgery, since this type of surgical intervention has come into practice relatively recently. Unfortunately, at the present time in Russia bariatric surgery is not an affordable and popular treatment for morbid obesity (MO). Nevertheless, it is extremely important to change the current situation, since bariatric treatment is an optimal and effective solution to socially significant diseases such as MO or type 2 diabetes mellitus.
- 21 December 2019
- Published by Endocrinology Research Centre in Obesity and metabolism
- Vol. 16 (3) , 3-10
Open AccessMultiple effects of bariatric surgery on human biochemical status
Beneficial effect of bariatric surgery is expressed not only in reducing body weight, but also in improving the functioning of the body as a whole. On the one hand, numerous studies devoted to the investigations of specific mechanisms of the influence of bariatric surgery on the general condition of an organism testify to the enormous interest of scientists in this problem. On the other hand, the range of changes is so vast that it covers almost all physiological and biochemical processes. The most noticeable response to bariatric surgery is from the digestive (including the composition of the microbiota), immune (reducing the level of systemic and local inflammation), cardiovascular (reducing the risks of atherosclerosis and other diseases) systems. Partial or complete compensation of type 2 diabetes mellitus and metabolic syndrome also occurs. Among the variety of data, there is insufficient research on only standard biomarkers: leptin, C-reactive protein, interleukin 6, etc. A detailed study of the profiles of both circulating biomarkers and local ones is necessary. At the same time, it is obligate to continue to accumulate evidence on the positive effect of bariatric surgery, since this type of surgical intervention has come into practice relatively recently. Unfortunately, at the present time in Russia bariatric surgery is not an affordable and popular treatment for morbid obesity (MO). Nevertheless, it is extremely important to change the current situation, since bariatric treatment is an optimal and effective solution to socially significant diseases such as MO or type 2 diabetes mellitus.